Statistics

Total Visits

Views
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients98

Select a period of time:

Number of views in the range

Views
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients31

Views

Views
December 20252
January 20261
February 20260
March 20264
April 20269
May 20264
June 202611
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States15
Netherlands5
France3
Australia1
Switzerland1
Germany1
Dominican Republic1
Mexico1
Poland1
Sweden1
 

Top cities views

Views
Groningen5
San Jose4
Los Angeles3
Ashburn2
Audun-le-Tiche1
Breuillet1
Dakar1
Dortmund1
Monterrey1
Queens1